McKensie Mack Group (MMG) LLC – Trademark Portfolio

Entity Type: 16

McKensie Mack Group (MMG) LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 4 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include ANTI-CAPITALIST CEO, WHITE SUPREMACY ZODIAC, and RACIAL EQUITY AND BELONGING AUDIT (REBA). The owner is based in Chicago, IL.

1507 E. 53rd Street, #276

Chicago, IL 60615

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

McKensie Mack Group (MMG) LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (4 filings)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does McKensie Mack Group (MMG) LLC have?

McKensie Mack Group (MMG) LLC has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.

What trademark classes does McKensie Mack Group (MMG) LLC file in?

McKensie Mack Group (MMG) LLC files trademarks across 1 Nice Classification class. The most active classes are Class 41 (Education & Entertainment). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are McKensie Mack Group (MMG) LLC's most well-known trademarks?

McKensie Mack Group (MMG) LLC's registered trademark portfolio includes well-known marks such as ANTI-CAPITALIST CEO, WHITE SUPREMACY ZODIAC, and RACIAL EQUITY AND BELONGING AUDIT (REBA). These are among 3 currently registered trademarks in the portfolio.

What is McKensie Mack Group (MMG) LLC's trademark registration success rate?

McKensie Mack Group (MMG) LLC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.